Cellenkos' CK0803 granted US FDA Fast Track designation for ALS

European Commission grants orphan designation for Vanda's imsidolimab

CureGene commences dosing in Phase I trial of CG-0416

Genetic Analysis launches microbiome test at Centre for Digestive Diseases in Sydney

Can-Fite reports preclinical data supporting Phase IIb pancreatic cancer study

AlzeCure completes QuantumCell transaction with USD12m upfront payment

Graviton BioScience's Investigational New Drug (IND) application for GV101 cleared for Friedreich's ataxia treatment

Alfasigma to acquire Nordic Pharma, expanding specialty care portfolio

Kodiak Sciences enrols first patients in KSI-501 Phase 3 ALTO trial in patients with diabetic macular oedema

European Commission approves RINVOQ for severe alopecia areata

Synlogic and Caldera Therapeutics agree merger

Harbour BioMed and Sinopharm establish innovation R&D consortium

Zoetis introduces Portela for feline osteoarthritis pain relief in Canada and EU

Arch Biopartners engages private lab to advance IL-32 chronic kidney disease programme

Vanda Pharmaceuticals reports positive EMA opinion on orphan drug designation for imsidolimab in generalised pustular psoriasis